ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00013286
  Purpose

This project will identify risk factors for diabetic foot ulcer by studying the relationship between endothelial dysfunction and foot ulcer risk. A fundamental defect in type 1 and 2 diabetic subjects is impaired vasodilatory reserve which is reflected in the dysfunction of endothelium-dependent vasodilation. Findings thus far point to an important role of the microvasculature in the development of diabetic foot ulcer and amputation.

In this study a a well-characterized cohort of 750 diabetic veterans without foot ulcer will be followed over 3-years.


Condition Intervention Phase
Diabetic Foot Ulcers
Device: Prevention Diabetic Foot Ulcer
Phase II

MedlinePlus related topics:   Diabetic Foot    Foot Health   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Prospective
Official Title:   A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk

Further study details as provided by Department of Veterans Affairs:

Estimated Enrollment:   750
Study Start Date:   October 1999
Study Completion Date:   September 2002

Detailed Description:

Prevention of foot ulcer should result in a reduction in the risk of lower limb amputation. We propose to identify risk factors for diabetic foot ulcer by studying the relationship between endothelial dysfunction and foot ulcer risk. It has been proposed that impaired vasoregulation in diabetic patients leads to the development and perpetuation of chronic foot ulceration via failure of the normal hyperemic response to injury. A fundamental defect that has been demonstrated in type 1 and 2 diabetic subjects is impaired vasodilatory reserve, which reflects dysfunction of endothelium-dependent vasodilation. Our findings thus far point to an important role of the microvasculature in the development of diabetic foot ulcer and amputation, with our demonstration of higher foot ulcer and lower-limb amputation risk in relation to lower dorsal foot transcutaneous oxygen level. The role of endothelial dysfunction in relation to diabetic foot ulcer risk has not previously been studied.

We will follow a well-characterized cohort of 750 diabetic veterans without foot ulcer over 3-year after obtaining baseline measures of endothelial function using iontophoretic application of acetylcholine to induce cutaneous endothelium-dependent vasodilation on the dorsal foot. Iontophoresis permits noninvasive delivery of ionic drugs cutaneously without damage to the skin or systemic effects. Change in microvascular flow will be measured using a laser Doppler imager (Moor LDI) over a 4x4 cm area divided into 18496 measurement sites. Endothelial function will be defined as the difference between readings before and after the iontophoretic application of a 1% acetylcholine solution at a current of 0.2 mA for 1 minute, with higher readings reflecting better endothelial function. These techniques are the accepted standard method for assessment of endothelium-dependent vasodilation in the cutaneous microvasculature. Additional measurements will be obtained on other ulcer risk factors to assess whether endothelial dysfunction independently influences foot ulcer risk, or whether it is merely a marker for different pathophysiologic conditions responsible for higher risk (eg., sensory neuropathy). Possible confounding factors considered will include sensory and autonomic neuropathy; dorsal foot transcutaneous oximetry; macrovascular function assessed with Doppler blood pressures; diabetes characteristics; in-shoe plantar pressure (F-scan), medication use, and foot deformity.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Diabetic patients with foot ulcers

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00013286

Locations
United States, Washington
VAMC, Seattle, WA    
      Seattle, Washington, United States

Sponsors and Collaborators

Investigators
Investigator:     John Fryer, Ph.D. Asst. Director     Program Analysis and Review Section (PARS), Rehabilitation Research & Development Service    
Investigator:     Wijegupta Ellepola, Program Analyst     Program Analysis & Review Section (PARS), Rehabilitation Research & Development Service    
  More Information

Study ID Numbers:   A2016R
First Received:   March 14, 2001
Last Updated:   December 12, 2007
ClinicalTrials.gov Identifier:   NCT00013286
Health Authority:   United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Diabetes mellitus, foot ulcer, endothelium  

Study placed in the following topic categories:
Foot Ulcer
Skin Diseases
Diabetic Neuropathies
Ulcer
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Foot Diseases
Diabetic Angiopathies
Endocrinopathy
Skin Ulcer
Diabetes Complications
Diabetic Foot
Leg Ulcer

Additional relevant MeSH terms:
Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers